Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06588153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Name: A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China — clinical trial record (NCT06588153)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 4

SponsorAmgen

Started2025-05-24

View on ClinicalTrials.gov ↗

The main objective of this study is to evaluate the efficacy of Prolia® in improving bone mass density (BMD) of lumbar spine at month 12.

Amendment history 1 change detected by DataLookout

2026-05-28

Trial status changed: Recruiting → Active, Not Recruiting

Trial Details

NCT Number	NCT06588153
Lead Sponsor	Amgen
Conditions	Glucocorticoid-induced Osteoporosis
Enrollment	102 participants
Start Date	2025-05-24
Primary Completion	2027-04-27 (estimated)
Study Completion	2027-04-27 (estimated)
Updated on ClinicalTrials.gov	2026-05-27